Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p36
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 36/191)
Character Range: 9868655–9883837

or more of the following contraindications to topical corticosteroids:
                                                                                                                                                                                                                                (i) perioral dermatitis; (ii) periorbital dermatitis; (iii) rosacea; (iv) epidermal atrophy; (v) dermal atrophy; (vi) allergy to topical corticosteroids; (vii) cataracts; (viii) glaucoma; (ix) raised intraocular pressure; AND
                                                                                                                                                                                                                               Patient must not receive more than two 15 g packs of PBS-subsidised pimecrolimus per 6-month period.
C5483               P5483          CN5483           Tobramycin                                                                                                                                                                 Invasive ocular infection

C5487               P5487          CN5487           Clindamycin                                                                                                                                                                Gram-positive coccal infections
                                                                                                                                                                                                                               The condition must not be able to be safely and effectively treated with a penicillin.
C5489               P5489          CN5489           Zolmitriptan                                                                                                                                                               Migraine attack
                                                                                                                                                                                                                               The condition must have usually failed to respond to analgesics in the past.
C5490               P5490          CN5490           Tobramycin                                                                                                                                                                 Septicaemia, proven

C5491               P5491          CN5491           Lanthanum                                                                                                                                                                  Hyperphosphataemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Compliance with Authority Required procedures - Streamlined Authority Code 5491
                                                                                                                                                                                                                               Maintenance following initiation and stabilisation
                                                    Sevelamer                                                                                                                                                                  The condition must not be adequately controlled by calcium; AND
                                                                                                                                                                                                                               Patient must have a serum phosphate of greater than 1.6 mmol per L at the commencement of therapy; or
                                                    Sucroferric oxyhydroxide                                                                                                                                                   The condition must be where a serum calcium times phosphate product is greater than 4 at the commencement of therapy; AND
                                                                                                                                                                                                                               The treatment must not be used in combination with any other non-calcium phosphate binding agents; AND
                                                                                                                                                                                                                               Patient must be undergoing dialysis for chronic kidney disease.
C5498               P5498          CN5498           Tobramycin                                                                                                                                                                 Pseudomonas aeruginosa infection
                                                                                                                                                                                                                               Patient must have cystic fibrosis; AND
                                                                                                                                                                                                                               The treatment must be systemic.
C5499               P5499          CN5499           Tobramycin                                                                                                                                                                 Suspected Pseudomonal eye infection

C5506               P5506          CN5506           Magnesium                                                                                                                                                                  Hypomagnesaemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 5506
                                                                                                                                                                                                                               Patient must be an Aboriginal or a Torres Strait Islander person.
C5509               P5509          CN5509           Tiotropium                                                                                                                                                                 Bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease
                                                                                                                                                                                                                               Long-term maintenance treatment
C5512               P5512          CN5512           Lansoprazole                                                                                                                                                               Scleroderma oesophagus

                                                    Omeprazole

                                                    Pantoprazole

                                                    Rabeprazole

C5516               P5516          CN5516           Topiramate                                                                                                                                                                 Seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures - Streamlined Authority Code 5516
                                                                                                                                                                                                                               Patient must have partial epileptic seizures; or
                                                                                                                                                                                                                               Patient must have primary generalised tonic-clonic seizures; or
                                                                                                                                                                                                                               Patient must have seizures of the Lennox-Gastaut syndrome; AND
                                                                                                                                                                                                                               The condition must have failed to be controlled satisfactorily by other anti-epileptic drugs.
C5519               P5519          CN5519           Tobramycin                                                                                                                                                                 Infection where positive bacteriological evidence confirms that this antibiotic is an appropriate therapeutic agent

C5520               P5520          CN5520           Tobramycin                                                                                                                                                                 Proven Pseudomonas aeruginosa infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with Authority Required procedures - Streamlined Authority Code 5520
                                                                                                                                                                                                                               Patient must have cystic fibrosis; AND
                                                                                                                                                                                                                               The treatment must be for management.
C5522               P5522          CN5522           Anastrozole                                                                                                                                                                Breast cancer
                                                                                                                                                                                                                               The condition must be hormone receptor positive.
                                                    Exemestane

                                                    Letrozole

                                                    Tamoxifen

C5526               P5526          CN5526           Panitumumab                                                                                                                                                                Metastatic colorectal cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 5526
                                                                                                                                                                                                                               Initial Treatment
                                                                                                                                                                                                                               Patient must have RAS wild-type metastatic colorectal cancer; AND
                                                                                                                                                                                                                               Patient must have a WHO performance status of 0 or 1; AND
                                                                                                                                                                                                                               The condition must be previously untreated; AND
                                                                                                                                                                                                                               The treatment must be in